SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-063776
Filing Date
2023-11-14
Accepted
2023-11-14 16:31:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a__sept_2023_pipe.htm DEFA14A 45977
  Complete submission text file 0000950170-23-063776.txt   47068
Mailing Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104
Business Address 2100 EAST 54TH STREET NORTH SIOUX FALLS SD 57104 605-679-6980
SAB Biotherapeutics, Inc. (Filer) CIK: 0001833214 (see all company filings)

IRS No.: 853899721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39871 | Film No.: 231407068
SIC: 2836 Biological Products, (No Diagnostic Substances)